1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 2:Time intensity curves of tumors as shown by dynamic MR imaging
Case No. Curve Types A B C1 C2 C3 C4 D E WA 1 + (41–50) + WA 2 + (39–50) + WA 3 + (22–38) WA 4 + (50–58) + WA 5 + (3–54) WA 6 + (45) WA 7 + (39) WA 8 + (40–52) WA 9 + (97) WA10 + (45) WA11 + (52) WA12 + (22–32) WA13 + (50) + (29) WA14 + (22–47) + WA15 + (18) + WA16 + (73–102) WA17 + (45) + (0) + WA18 + (46–61) WA19 + (11–55) AC 1 + (22) AC 2 + (25) AC 3 + (20) + AC 4 + (18–24) + (4.4) ME 1 + (38) + (11) ACC1 + (15) + (0) ACC2 + (17) + (0) + SD 1 + (11) + (6) + SD 2 + (0) SD 3 + (12) + SD 4 + (0) SD 5 + (16–27) + (0) SQ 1 + (18–35) BC 1 + (16) + (5) + (0) CEP1 + (0) CEP2 + (6) + (0) + CEP3 + (25) + (4) +
Note.—WA indicates Warthin tumor; AC, acinic cell adenocarcinoma; ME, mucoepidermoid carcinoma; ACC, adenoid cystic carcinoma; SD, salivary duct carcinoma; SQ, squamous cell carcinoma; BC, basal cell adenocarcinoma; CEP, carcinoma ex pleomorphic adenoma. Washout ratio, shown in parentheses, is expressed as a percentage.